Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Antiphospholipid Syndrome MeSH Descriptor Data 2026


MeSH Heading
Antiphospholipid Syndrome
Tree Number(s)
C20.111.197
Unique ID
D016736
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016736
Scope Note
The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
Entry Term(s)
Anti-Phospholipid Antibody Syndrome
Anti-Phospholipid Syndrome
Antiphospholipid Antibody Syndrome
Hughes Syndrome
NLM Classification #
QW 545
Previous Indexing
Phospholipids/immunology (1977-1991)
Public MeSH Note
92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992
Online Note
use ANTIPHOSPHOLIPID SYNDROME to search PHOSPHOLIPID ANTIBODY SYNDROME 1992
History Note
92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992
Date Introduced
1992/01/01
Last Updated
2014/06/13
Antiphospholipid Syndrome Preferred
page delivered in 0.136s